Delivery Order SPE2DB22D3004-SPE2DB25FSH96
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $13,650.00 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, with completion scheduled for August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime pharmaceutical distributor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for pharmaceutical and medical supply products valued at $1,386.84. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,379.98 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $158,944.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The work will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,854.00 to AmerisourceBergen Drug Corp on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M and extending through December 2026. The delivery order is issued for pharmaceutical products...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,288.33 to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and runs through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,394.30 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH96Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,024.40 to AmerisourceBergen Drug Corp on September 8, 2025, for pharmaceutical and medical supply products under contract number 4569359419. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be executed at the company's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor that supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's prime IDC with DLA valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent track record of competitively awarded contracts with firm fixed pricing demonstrates its capability to meet federal procurement requirements efficiently, ranging from small-value transactions to orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 9/8/25 |